John Wang
I’m interested in developing advanced cancer therapies by targeting immune responses, including exploring antibody mechanisms, bi-specific antibodies, and antibody drug conjugates (ADCs) to improve treatment efficacy. Additionally, I aim to optimize cancer vaccine strategies, incorporating insights from RNA vaccine research and novel vaccine designs to enhance immune system engagement.
